Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

    Sidsel Arnspang Pedersen, Odense Universitetshospital, Faculty of Health Sciences, University of Southern Denmark, Odense, Syddansk Universitet, David Gaist, Odense Universitetshospital, Faculty of Health Sciences, University of Southern Denmark, Odense,
  • Sigrun Alba Johannesdottir Schmidt
  • Lisbet Rosenkrantz Hölmich, Gentofte Hospital, Søren Friis, Aarhus University Hospital, Kræftens Bekæmpelse, Københavns Universitet, Anton Pottegård, Syddansk Universitet
Original languageEnglish
JournalJournal of the American Academy of Dermatology
Volume78
Issue number4
Pages (from-to)673-681.e9
ISSN0190-9622
DOIs
StatePublished - 1 Apr 2018

    Research areas

  • antihypertensives, cancer risk, hydrochlorothiazide, nonmelanoma skin cancer, pharmacoepidemiology, pharmacology, skin cancer

See relations at Aarhus University Citationformats

ID: 129356868